Related Experiment Video

Updated: Feb 15, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.3K

[Research Progress on Effect of JAK Inhibitors on Myelofibrosis- Review]

Jun-Xiu Liu1, Wei Chen1, Kai-Lin Xu1

  • 1Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|February 6, 2018
PubMed

Insights

Janus kinase (JAK) inhibitors offer a new treatment strategy for myelofibrosis, a challenging myeloproliferative neoplasm. These targeted therapies show efficacy in single or combination applications, improving patient outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Myelofibrosis (MF) is a complex myeloproliferative neoplasm with limited treatment options.
  • The identification of the Janus kinase 2 (JAK2) V617F mutation paved the way for targeted therapies.
  • JAK inhibitors represent a significant advancement in managing myelofibrosis.

Purpose of the Study:

  • To review the latest advancements in Janus kinase (JAK) inhibitors for myelofibrosis treatment.
  • To highlight the efficacy and applications of JAK inhibitors in clinical settings.
  • To discuss the role of JAK inhibitors in monotherapy, combination therapy, and during stem cell transplantation.

Main Methods:

  • Review of recent clinical trials and research on JAK inhibitors for myelofibrosis.
  • Analysis of data regarding the efficacy of JAK inhibitors in symptom relief and disease progression.
  • Exploration of combination strategies involving JAK inhibitors and other therapeutic agents.

Main Results:

  • JAK inhibitors have demonstrated significant clinical efficacy in treating myelofibrosis.
  • Single-agent JAK inhibitors can alleviate symptoms, slow disease progression, and improve survival.
  • Combination therapies utilizing JAK inhibitors offer expanded treatment choices, including during allogeneic hematopoietic stem cell transplantation.

Conclusions:

  • Janus kinase (JAK) inhibitors are a crucial therapeutic class for myelofibrosis patients.
  • These targeted agents provide effective options for symptom management and disease control.
  • The versatility of JAK inhibitors allows for diverse treatment strategies, enhancing patient care.

More Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.1K
Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.0K

Related Concept Videos

Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K